Multi-Cancer Early Detection (MCED) of Firefighters
1 other identifier
observational
2,000
1 country
1
Brief Summary
This study is an an observational prospective cohort research study to explore the performance of new blood and urine tests for the early detection of cancer among firefighters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2023
CompletedStudy Start
First participant enrolled
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
November 5, 2025
November 1, 2025
3.8 years
March 10, 2023
November 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sensitivity, specificity, positive and negative predictive performance values (PPV and NPV) to detect cancer using Elypta's MCED test, as measured in plasma, in urine, and in plasma and urine combined
Up to 7 years
Sensitivity, specificity, positive and negative predictive performance values to detect cancer using Proteotype's MCED test, as measured in plasma.
Up to 2030
Study Arms (1)
Firefighters who receive multi-cancer early detection (MCED) test
Interventions
multi-cancer early detection (MCED) test
Eligibility Criteria
Actively working firefighters of any adult age, any gender and any demographic group are eligible, as well as no limitations regarding general health status other than those specified in the protocol Eligibility Criteria.
You may qualify if:
- years of age or older
- Currently employed as a firefighter, full-time or part-time
- Taking part in Vincere's First Responder Cancer Screening Program
- Able to donate blood and urine sample
- Able to provide informed consent to participate in the study
You may not qualify if:
- Deemed medically unfit for sample donation
- Personal history of cancer in the last 5 years (with the exception of non-melanoma skin cancer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vincere Cancer Centerlead
- Elyptacollaborator
- Proteotypecollaborator
Study Sites (1)
Vincere Cancer Center
Scottsdale, Arizona, 85260, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Vershalee Shukla, MD
Vincere Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2023
First Posted
March 23, 2023
Study Start
March 21, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2030
Last Updated
November 5, 2025
Record last verified: 2025-11